Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 92 | ETA2023 | Next issue

45th Annual Meeting of the European Thyroid Association (ETA) 2023

Poster Presentations

Thyroid Cancer clinical 1

ea0092ps1-06-01 | Thyroid Cancer clinical 1 | ETA2023

Components of collaborative thyroid care clinics in the mississauga-halton regions in ontario, canada

Farahani Pendar

Background: The concept of collaborative thyroid care clinics (or networks), have been established over the last two decades, in many parts of the world.Objective: What are the main available components of collaborative community-based integrated thyroid programs in the Mississauga-Halton regions [West Greater Toronto Area (GTA), Ontario, Canada], that can provide opportunities for streamlining thyroid care?Method: Reviewing the av...

ea0092ps1-06-02 | Thyroid Cancer clinical 1 | ETA2023

Long-Term outcomes following initial therapy in differentiated thyroid cancer (DTC) in china: DTCC 2nd stage study analysis 2014-2022

Ming Jie , Zhu Jing-Qiang , Sun Hui , Zhang Hao , Wang Jun , Xie Lei , Cheng Ruo-Chuan , Li Xing-Rui , Huang Tao

Objectives: We previously reported the outcome of 1-year follow-up of 2013 DTC patients in the DTCC (differentiated thyroid cancer in China) 1st stage Study. Using the retrospectively gathered information, we sought to observe the long-term follow-up and prognosis of these patients with DTC undergoing thyroid surgery.Methods: This multicenter, noninterventional study was conducted at eight tertiary hospitals across China. Data from the patient...

ea0092ps1-06-03 | Thyroid Cancer clinical 1 | ETA2023

Clinical and surgical challenges of local relapse of papillary thyroid carcinoma (PTC)

Czarniecka Agnieszka , Wozniak Grzegorz , Zeman Marcin , Cortez Alexander J. , Stobiecka Ewa , Chmielik Ewa , Oczko-Wojciechowska Malgorzata , Krajewska Jolanta , Handkiewicz-Junak Daria

Aim: The assessment of the disease course and selected clinicopathological factors associated with recurrence risk and the effectiveness of surgical treatment of PTC patients.Material and Methods: The retrospective analysis of 260 PTC patients selected from 403 patients operated on for recurrent thyroid cancer between 2002 and 2018 was performed. All statistical analyses were done using the programming environment R (v. 4.0.2).Resu...

ea0092ps1-06-04 | Thyroid Cancer clinical 1 | ETA2023

Predictive factors for central neck compartment lymphnodes metastases’ in sporadic medullary thyroid cancer patients

Cappagli Virginia , Matrone Antonio , Piaggi Paolo , Bottici Valeria , Agate Laura , Molinaro Eleonora , Torregrossa Liborio , Elisei Rossella

Introduction: Total thyroidectomy (TT) plus central neck compartment (CC) lymphnode dissection is still the recommended initial gold standard treatment for medullary thyroid cancer (MTC), even in the absence of a pre-surgical positive neck US evidence of lymphnode metastases. Considering the risk of surgical complications of this prophylactic surgery and the low rate of histologic finding of CC lymphnode metastases, a more tailored lymphnode’ surgery should be proposed. A...

ea0092ps1-06-05 | Thyroid Cancer clinical 1 | ETA2023

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha & beta testing

Koot Rosalie , Hermens Rosella P.M.G. , Ottevanger Nelleke , Teodora Netea-Maier Romana , Stalmeier Peep

Background: Patient decision aids (PtDAs) are structured clinical tools that facilitate shared decision making. Two important treatment decisions for patients with differentiated thyroid cancer (DTC), which could benefit from PtDAs, are: 1) the extent of surgery decision in patients with low-risk DTC and 2) the decision to start or delay starting the treatment with Tyrosine Kinase Inhibitors (TKIs) in patients with advanced tumors.Material and methods: P...

ea0092ps1-06-06 | Thyroid Cancer clinical 1 | ETA2023

Papillary thyroid carcinoma associated with thyroiditis: about a series

Bouchenna Amira , Tibouk Albelghani , Ibrahim Ghennam , Aitseddik Sarah , Boumaraf Khawla , Ould Kablia Samia

Introduction: The association between papillary thyroid carcinoma and thyroiditis was first reported in 1955 by Daily, in 2023 if this association is well established, it still continues to be talked about. Does cancer precede thyroiditis or does thyroiditis induce cancer and when the two combine does cancer have a better prognosis?Material and methods: We report a prospective study carried out in a hospital center in Algeria between 2020 and 2022 which ...

ea0092ps1-06-07 | Thyroid Cancer clinical 1 | ETA2023

Thyroid cancer in ukrainian children during 35 years after the accident at the chernobyl nuclear power plant

Zelinska Natalia , Globa Eugenia

Background: According to the statistics of the Ministry of Health of Ukraine, before the accident at the Chernobyl nuclear power plant, the incidence of thyroid cancer in children under 14 years of age was on average 0.04 per 100,000 children, however long-term consequences of the accident have not been analyzed.Material and methods: We studied the incidence of thyroid cancer during the last 35 years in Ukraine in children under the age of 14 and 18 y.o....

ea0092ps1-06-08 | Thyroid Cancer clinical 1 | ETA2023

Hypertension during lenvatinib for advanced thyroid cancer: a diagnostic and therapeutic algorithm for its management

Daniele Ceruti , Carla Colombo , Leo Simone De , Grzegorz Bilo , Matteo Trevisan , Noemi Giancola , Claudia Moneta , Gianfranco Parati , Luca Persani , Laura Fugazzola

Background: Hypertension (HTN) is the most frequent adverse event during treatment with Lenvatinib (LEN) for advanced Radioactive Iodine-Resistant Thyroid Cancer (RAI-R TC), but data on its best therapeutic management are limited.Objectives: To assess incidence, features and best management of LEN-related HTN in a consecutive single tertiary-care Centre.Methods: Evaluation included 29 patients treated with LEN, followed for a mean ...

ea0092ps1-06-09 | Thyroid Cancer clinical 1 | ETA2023

Four cases of anaplastic thyroid carcinoma

Ikoma Ryo , Takahata Yoshinobu , Kawano Toshiro , Oridate Nobuhiko

Introduction: Anaplastic thyroid carcinoma (ATC) carries an extremely poor prognosis. The reported median survival time is 3-9 months and one year survival rate is 18-20%. Here we report 4 cases of ATC.Case reports: Case 1: An 82 year-old female presented with rapidly progressive anterior neck swelling. She underwent hemi-thyroidectomy and D1 dissection. Pathological diagnosis was ATC, T4aN0. External beam radiotherapy (EBRT) to the whole neck was admini...